Boulder, CO, United States of America

Mark W Tibbitt

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: The General Hospital Corporation, University of Colorado. Active years: 2015-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark W Tibbitt. Retrieved from https://idiyas.com/inventor/mark-w-tibbitt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2015-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Mark W Tibbitt

Introduction

Mark W Tibbitt is a notable inventor based in Boulder, CO (US). He has made significant contributions to the field of biomedical engineering, particularly in the development of photodegradable hydrogels and microparticles. With a total of 2 patents, Tibbitt's work focuses on innovative methods for cell capture and protein delivery.

Latest Patents

Tibbitt's latest patents include "Selective capture and release of rare mammalian cells using photodegradable hydrogels in a microfluidic platform." This invention discloses photodegradable hydrogels and associated kits designed for the selective capture and release of cells. The hydrogels are formed through cross-linking a macromer with a polymeric backbone and a cell-binding moiety, allowing for the detection of rare cell types in biological fluids.

Another significant patent is "Photodegradable groups for tunable polymeric materials." This patent presents a photodegradable microparticle system that can entrap and deliver bioactive proteins to cells during culture. The system enables a variety of spatiotemporally regulated release profiles, allowing researchers to explore how protein presentation can influence cell function.

Career Highlights

Throughout his career, Tibbitt has worked with esteemed institutions such as the University of Colorado and The General Hospital Corporation. His research has advanced the understanding of how materials can be engineered for biomedical applications, particularly in cell culture and protein delivery.

Collaborations

Tibbitt has collaborated with notable colleagues, including Kristi S Anseth and April M Kloxin. These partnerships have contributed to the innovative research and development of new materials and methods in the field.

Conclusion

Mark W Tibbitt's contributions to the field of biomedical engineering through his patents and collaborations highlight his role as a leading inventor. His work continues to influence advancements in cell capture and protein delivery systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…